Sebi considers bringing back open market buybacks via stock exchange route

The pharma sector, often characterized by strong cash flows, could see increased capital returns to shareholders through this mechanism. Companies like Aurobindo Pharma, already considering buybacks, stand to benefit.

Look for pharma companies with robust balance sheets and consistent free cash flow generation that might announce buybacks; potential for short-term price appreciation.

For Indian markets, this story mainly matters for the Financial Services, Information Technology, Pharmaceuticals pocket. The current signal is bullish, so traders should watch whether the effect spreads across the sector or stays limited to a single name.

Watch whether the market validates this read through price action, volume, and breadth. If the headline matters, the signal should show up in execution, not just in commentary.

• •Sebi is considering bringing back open market share buybacks via stock exchanges.
• •This method was previously stopped due to transparency and price discovery concerns.
• •The regulator aims to improve capital returns for firms and make capital allocation more dynamic.
• •Companies could soon have this as an additional option alongside tender offers.
• •Risk flag: Regulatory details of the new buyback mechanism are yet to be finalized.